Clinical Trial Update: Canagliflozin in Advanced Renal Disease With MRI Endpoints [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating canagliflozin in advanced kidney disease with MRI endpoints is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Chronic Kidney Disease Stage
• End-stage Renal Disease

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: ESRD, CKD Stage 4, CKD Stage 5 | Phase 2 | Status: RECRUITING